We are live on ! Find out more
CRB

Chad R. Baker Portfolio holdings

AUM $620M
1-Year Est. Return 42.67%
This Fund
S&P 500
This Quarter Est. Return
-4.33%
1 Year Est. Return
+42.67%
3 Year Est. Return
+108.31%
5 Year Est. Return
+132.07%
10 Year Est. Return
+563.15%
AUM
$396M
AUM Growth
-$27.1M
Cap. Flow
-$6.18M
Cap. Flow %
-1.56%
Top 10 Hldgs %
47.08%
Holding
55
New
3
Increased
21
Reduced
2
Closed
2

Top Buys

Rank Stock Value
1
CRSP icon
CRISPR Therapeutics
CRSP
+$2.69M
2
IFF icon
International Flavors & Fragrances
IFF
+$2.35M
3
NET icon
Cloudflare
NET
+$2.06M
4
DHR icon
Danaher
DHR
+$93K
5
NVO
Novo Nordisk
NVO
+$91.6K

Top Sells

Rank Stock Value
1
SYY icon
Sysco
SYY
+$7.66M
2
DIS icon
Walt Disney
DIS
+$4.95M
3
ILMN icon
Illumina
ILMN
+$1.7M
4
AAPL icon
Apple
AAPL
+$3.67K

Sector Composition

Rank Sector Weight
1 Technology 31.3%
2 Healthcare 18.53%
3 Industrials 17.55%
4 Consumer Discretionary 12.75%
5 Communication Services 9.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BDX icon
51
Becton Dickinson
BDX
$51.6B
$427K 0.11%
1,650
+275
+20% +$74.3K
MDT icon
52
Medtronic
MDT
$117B
$326K 0.08%
4,165
+610
+17% +$51.1K
SJM icon
53
J.M. Smucker
SJM
$14.1B
$209K 0.05%
1,700
– –
DIS icon
54
Walt Disney
DIS
$187B
– –
-55,490
Closed -$4.95M
SYY icon
55
Sysco
SYY
$39.3B
– –
-103,185
Closed -$7.66M
1 2
3

Similar funds

PLU
Performa Ltd (US) Charleston, South Carolina $620M AUM 19.43% 1-Year Est. Return
RR
Robotti Robert $620M AUM 55.18% 1-Year Est. Return
TAIM
Te Ahumairangi Investment Management Wellington, New Zealand $620M AUM 14.43% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return
GPWA
Great Point Wealth Advisors Boston, Massachusetts $619M AUM 14.72% 1-Year Est. Return
MAC
Mason & Associates (California) Los Angeles, California $619M AUM 29.44% 1-Year Est. Return
BT
Brandywine Trust Hockessin, Delaware $621M AUM 15.59% 1-Year Est. Return
IC
Intel Corp Santa Clara, California $621M AUM 34.06% 1-Year Est. Return

Chad R. Baker's Q3 2023 Portfolio in Review

As of Q3 2023, Chad R. Baker held 55 positions worth $396M, down 6.4% from $423M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Chad R. Baker's Q3 2023 filing shows 3 new, 21 increased, 2 reduced and 2 closed positions. Its largest new stake was CRISPR Therapeutics: 52,100 shares worth $2.36M. The largest sale was Sysco, an estimated $7.66M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 31% a quarter earlier, followed by Healthcare and Industrials.

  • Chad R. Baker's largest Q3 2023 buy was CRISPR Therapeutics: 52,100 shares worth $2.36M.
  • Chad R. Baker added most to Danaher in Q3 2023, an estimated $93K increase.
  • Chad R. Baker's biggest Q3 2023 reduction was Illumina, cutting an estimated $1.7M.
  • Chad R. Baker fully exited Sysco in Q3 2023, selling an estimated $7.66M.
  • Chad R. Baker's ten largest holdings make up 47% of its $396M portfolio in Q3 2023.
  • Chad R. Baker opened 3 new positions and closed 2 in Q3 2023.
  • Chad R. Baker's portfolio value fell 6.4% quarter-over-quarter to $396M.

Based on Chad R. Baker's 13F filing for Q3 2023, filed 17 Oct 2023.